Table 5. Operative and postoperative outcomes of mitral valve replacement + tricuspid ring annuloplasty subgroups.
| Total (n=135) | ACC group (n=65) | BH group (n=70) | |||||||||||||
| n | % | n | % | n | % | ||||||||||
| Prolonged inotropic dependency* | 89 | 66 | 50 | 77 | 39 | 56 | 0.0112 | ||||||||
| Postoperative RBBB | 12 | 9 | 6 | 9 | 6 | 9 | 1.00 | ||||||||
| Postoperative LBBB | 13 | 10 | 10 | 15 | 3 | 4 | 0.04 | ||||||||
| Need for temporary pacemaker | 24 | 18 | 13 | 20 | 11 | 16 | 0.65 | ||||||||
| In-hospital mortality | 8 | 6 | 4 | 6 | 4 | 6 | 1.00 | ||||||||
| Discharged patients | |||||||||||||||
| n=127 | n=61 | n=66 | |||||||||||||
| n | % | n | % | n | % | p | |||||||||
| Permanent pacemaker requirement | 11 | 8 | 9 | 13 | 2 | 3 | 0.0259 | ||||||||
| Indication for permanent pacemaker implantation High degree AV block Sinus node dysfunction |
7 6 |
64 36 |
6 3 |
67 33 |
1 1 |
50 50 |
1.00 | ||||||||
| > 2+ TR (at discharge) | 12 | 9 | 10 | 16 | 2 | 3 | 0.0136 | ||||||||
| > 2+ TR (at first year) | 19 | 15 | 14 | 23 | 5 | 8 | 0.0235 | ||||||||
| ACC: Aortic cross-clamping; BH: Beating heart; RBBB: Right bundle branch block; LBBB: Right bundle branch block; AV: Atrioventricular; TR: Tricuspid regurgitation; * Postoperative inotrope/vasopressor use including dobutamine (5 μg/kg/min), dopamine (>5 μg/kg/min), norepinephrine (>0.1 μg/kg/min), milrinone, epinephrine, phenylephrine, and vasopressin 24 hours after skin closure was defined as prolonged inotropic dependency. | |||||||||||||||